| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 5.95e-05 | 46 | 33 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 8.60e-05 | 52 | 33 | 3 | GO:0035255 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 3.21e-04 | 81 | 33 | 3 | GO:0035254 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 8.76e-04 | 459 | 33 | 5 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 9.28e-04 | 465 | 33 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.25e-03 | 129 | 33 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.35e-03 | 758 | 33 | 6 | GO:0015318 | |
| GeneOntologyMolecularFunction | channel activity | 1.59e-03 | 525 | 33 | 5 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.60e-03 | 526 | 33 | 5 | GO:0022803 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 1.70e-03 | 793 | 33 | 6 | GO:0015075 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.96e-03 | 151 | 33 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.00e-03 | 152 | 33 | 3 | GO:0022843 | |
| GeneOntologyMolecularFunction | gated channel activity | 2.15e-03 | 334 | 33 | 4 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.36e-03 | 343 | 33 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | channel regulator activity | 2.93e-03 | 174 | 33 | 3 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 3.07e-03 | 177 | 33 | 3 | GO:0141108 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 3.32e-03 | 182 | 33 | 3 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 3.43e-03 | 184 | 33 | 3 | GO:0022832 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 3.44e-03 | 627 | 33 | 5 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 4.39e-03 | 664 | 33 | 5 | GO:0008324 | |
| GeneOntologyMolecularFunction | transporter activity | 4.45e-03 | 1289 | 33 | 7 | GO:0005215 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 5.16e-03 | 65 | 33 | 2 | GO:0004714 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor transport, postsynaptic endosome to lysosome | 1.71e-07 | 8 | 31 | 3 | GO:0098943 | |
| GeneOntologyBiologicalProcess | postsynaptic neurotransmitter receptor diffusion trapping | 8.70e-07 | 13 | 31 | 3 | GO:0098970 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor diffusion trapping | 8.70e-07 | 13 | 31 | 3 | GO:0099628 | |
| GeneOntologyBiologicalProcess | receptor diffusion trapping | 1.11e-06 | 14 | 31 | 3 | GO:0098953 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor internalization | 1.67e-06 | 58 | 31 | 4 | GO:0099590 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane neurotransmitter receptor levels | 4.30e-06 | 164 | 31 | 5 | GO:0099072 | |
| GeneOntologyBiologicalProcess | regulation of AMPA receptor activity | 6.91e-06 | 25 | 31 | 3 | GO:2000311 | |
| GeneOntologyBiologicalProcess | receptor localization to synapse | 1.54e-05 | 101 | 31 | 4 | GO:0097120 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.31e-05 | 112 | 31 | 4 | GO:0019226 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | 2.36e-05 | 233 | 31 | 5 | GO:0050806 | |
| GeneOntologyBiologicalProcess | trunk neural crest cell migration | 3.27e-05 | 6 | 31 | 2 | GO:0036484 | |
| GeneOntologyBiologicalProcess | trunk segmentation | 3.27e-05 | 6 | 31 | 2 | GO:0035290 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor transport | 3.39e-05 | 42 | 31 | 3 | GO:0099637 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, glutamatergic | 3.64e-05 | 43 | 31 | 3 | GO:0051968 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor localization to postsynaptic specialization membrane | 5.40e-05 | 49 | 31 | 3 | GO:0099645 | |
| GeneOntologyBiologicalProcess | protein localization to postsynaptic specialization membrane | 5.40e-05 | 49 | 31 | 3 | GO:0099633 | |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 5.47e-05 | 278 | 31 | 5 | GO:0031503 | |
| GeneOntologyBiologicalProcess | sympathetic ganglion development | 7.82e-05 | 9 | 31 | 2 | GO:0061549 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor activity | 8.07e-05 | 56 | 31 | 3 | GO:0099601 | |
| GeneOntologyBiologicalProcess | protein localization to lysosome | 9.93e-05 | 60 | 31 | 3 | GO:0061462 | |
| GeneOntologyBiologicalProcess | neural crest cell migration | 1.09e-04 | 62 | 31 | 3 | GO:0001755 | |
| GeneOntologyBiologicalProcess | mesenchymal cell migration | 1.20e-04 | 64 | 31 | 3 | GO:0090497 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to vacuole | 1.32e-04 | 66 | 31 | 3 | GO:0072666 | |
| GeneOntologyBiologicalProcess | receptor internalization | 1.53e-04 | 182 | 31 | 4 | GO:0031623 | |
| GeneOntologyBiologicalProcess | protein localization to postsynaptic membrane | 2.09e-04 | 77 | 31 | 3 | GO:1903539 | |
| GeneOntologyBiologicalProcess | protein localization to postsynapse | 2.34e-04 | 80 | 31 | 3 | GO:0062237 | |
| GeneOntologyBiologicalProcess | endosome to lysosome transport | 2.70e-04 | 84 | 31 | 3 | GO:0008333 | |
| GeneOntologyBiologicalProcess | neural crest cell development | 3.20e-04 | 89 | 31 | 3 | GO:0014032 | |
| GeneOntologyBiologicalProcess | protein localization to vacuole | 3.20e-04 | 89 | 31 | 3 | GO:0072665 | |
| GeneOntologyBiologicalProcess | ganglion development | 3.29e-04 | 18 | 31 | 2 | GO:0061548 | |
| GeneOntologyBiologicalProcess | embryonic pattern specification | 3.41e-04 | 91 | 31 | 3 | GO:0009880 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 3.53e-04 | 92 | 31 | 3 | GO:0051966 | |
| GeneOntologyBiologicalProcess | negative regulation of cell population proliferation | 4.59e-04 | 961 | 31 | 7 | GO:0008285 | |
| GeneOntologyBiologicalProcess | stem cell development | 4.64e-04 | 101 | 31 | 3 | GO:0048864 | |
| GeneOntologyBiologicalProcess | neural crest cell differentiation | 5.05e-04 | 104 | 31 | 3 | GO:0014033 | |
| GeneOntologyBiologicalProcess | sympathetic nervous system development | 5.91e-04 | 24 | 31 | 2 | GO:0048485 | |
| GeneOntologyBiologicalProcess | protein localization to synapse | 6.77e-04 | 115 | 31 | 3 | GO:0035418 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 7.85e-04 | 121 | 31 | 3 | GO:0051899 | |
| GeneOntologyBiologicalProcess | regulation of platelet-derived growth factor receptor signaling pathway | 8.06e-04 | 28 | 31 | 2 | GO:0010640 | |
| GeneOntologyBiologicalProcess | branching involved in salivary gland morphogenesis | 8.06e-04 | 28 | 31 | 2 | GO:0060445 | |
| GeneOntologyBiologicalProcess | regulation of signaling receptor activity | 9.88e-04 | 131 | 31 | 3 | GO:0010469 | |
| GeneOntologyBiologicalProcess | reflex | 9.89e-04 | 31 | 31 | 2 | GO:0060004 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 1.01e-03 | 132 | 31 | 3 | GO:0035249 | |
| GeneOntologyBiologicalProcess | artery development | 1.03e-03 | 133 | 31 | 3 | GO:0060840 | |
| GeneOntologyBiologicalProcess | blastoderm segmentation | 1.26e-03 | 35 | 31 | 2 | GO:0007350 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 1.36e-03 | 559 | 31 | 5 | GO:0042391 | |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 1.40e-03 | 148 | 31 | 3 | GO:1902414 | |
| GeneOntologyBiologicalProcess | salivary gland morphogenesis | 1.49e-03 | 38 | 31 | 2 | GO:0007435 | |
| GeneOntologyBiologicalProcess | lysosomal transport | 1.49e-03 | 151 | 31 | 3 | GO:0007041 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 1.55e-03 | 337 | 31 | 4 | GO:0006898 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transport | 1.71e-03 | 589 | 31 | 5 | GO:0034762 | |
| GeneOntologyBiologicalProcess | salivary gland development | 1.90e-03 | 43 | 31 | 2 | GO:0007431 | |
| GeneOntologyBiologicalProcess | kidney development | 2.23e-03 | 372 | 31 | 4 | GO:0001822 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 2.32e-03 | 931 | 31 | 6 | GO:0098916 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 2.32e-03 | 931 | 31 | 6 | GO:0007268 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 2.43e-03 | 939 | 31 | 6 | GO:0099537 | |
| GeneOntologyBiologicalProcess | regulation of extrinsic apoptotic signaling pathway | 2.49e-03 | 181 | 31 | 3 | GO:2001236 | |
| GeneOntologyBiologicalProcess | renal system development | 2.55e-03 | 386 | 31 | 4 | GO:0072001 | |
| GeneOntologyBiologicalProcess | autonomic nervous system development | 2.56e-03 | 50 | 31 | 2 | GO:0048483 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 2.69e-03 | 392 | 31 | 4 | GO:0070588 | |
| GeneOntologyBiologicalProcess | vacuolar transport | 2.73e-03 | 187 | 31 | 3 | GO:0007034 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 2.87e-03 | 663 | 31 | 5 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 2.89e-03 | 664 | 31 | 5 | GO:0099177 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 2.94e-03 | 976 | 31 | 6 | GO:0099536 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.26e-07 | 157 | 32 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.30e-07 | 405 | 32 | 8 | GO:0045211 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.52e-07 | 583 | 32 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 5.40e-07 | 201 | 32 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 2.54e-06 | 817 | 32 | 9 | GO:0098978 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 3.60e-06 | 155 | 32 | 5 | GO:0098685 | |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 1.29e-05 | 30 | 32 | 3 | GO:0032281 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 4.43e-05 | 45 | 32 | 3 | GO:0008328 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 4.73e-05 | 46 | 32 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | postsynaptic density | 5.49e-05 | 451 | 32 | 6 | GO:0014069 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 6.08e-05 | 50 | 32 | 3 | GO:0098878 | |
| GeneOntologyCellularComponent | asymmetric synapse | 7.49e-05 | 477 | 32 | 6 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.00e-04 | 503 | 32 | 6 | GO:0099572 | |
| GeneOntologyCellularComponent | postsynapse | 1.14e-04 | 1018 | 32 | 8 | GO:0098794 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.24e-04 | 523 | 32 | 6 | GO:0098984 | |
| GeneOntologyCellularComponent | transporter complex | 1.63e-04 | 550 | 32 | 6 | GO:1990351 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.88e-04 | 73 | 32 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | receptor complex | 2.20e-04 | 581 | 32 | 6 | GO:0043235 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.54e-04 | 378 | 32 | 5 | GO:0034702 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 4.11e-04 | 1228 | 32 | 8 | GO:0036477 | |
| GeneOntologyCellularComponent | cation channel complex | 4.37e-04 | 235 | 32 | 4 | GO:0034703 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 1.11e-03 | 523 | 32 | 5 | GO:1902495 | |
| GeneOntologyCellularComponent | dendrite membrane | 3.32e-03 | 56 | 32 | 2 | GO:0032590 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 4.11e-03 | 212 | 32 | 3 | GO:0030666 | |
| GeneOntologyCellularComponent | neuron projection membrane | 6.99e-03 | 82 | 32 | 2 | GO:0032589 | |
| MousePheno | abnormal second pharyngeal arch morphology | 2.27e-05 | 29 | 27 | 3 | MP:0006338 | |
| MousePheno | abnormal CNS synaptic transmission | 6.07e-05 | 985 | 27 | 9 | MP:0002206 | |
| MousePheno | decreased miniature excitatory postsynaptic current amplitude | 7.50e-05 | 7 | 27 | 2 | MP:0014372 | |
| MousePheno | abnormal first pharyngeal arch morphology | 1.05e-04 | 48 | 27 | 3 | MP:0006337 | |
| MousePheno | abnormal synaptic transmission | 1.15e-04 | 1070 | 27 | 9 | MP:0003635 | |
| MousePheno | abnormal synaptic physiology | 1.21e-04 | 1076 | 27 | 9 | MP:0021009 | |
| MousePheno | abnormal inner ear canal morphology | 2.36e-04 | 63 | 27 | 3 | MP:0002729 | |
| MousePheno | small second pharyngeal arch | 2.77e-04 | 13 | 27 | 2 | MP:0006344 | |
| MousePheno | small first pharyngeal arch | 3.22e-04 | 14 | 27 | 2 | MP:0006341 | |
| MousePheno | abnormal miniature excitatory postsynaptic current amplitude | 3.71e-04 | 15 | 27 | 2 | MP:0014371 | |
| MousePheno | abnormal prepulse inhibition | 4.88e-04 | 542 | 27 | 6 | MP:0003088 | |
| Domain | VDCC_gsu | 2.80e-07 | 8 | 33 | 3 | IPR008368 | |
| Domain | Claudin | 1.60e-05 | 28 | 33 | 3 | IPR006187 | |
| Domain | PMP22_Claudin | 4.75e-05 | 40 | 33 | 3 | PF00822 | |
| Domain | PMP22/EMP/MP20/Claudin | 6.78e-05 | 45 | 33 | 3 | IPR004031 | |
| Domain | PHD | 3.11e-04 | 75 | 33 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 3.63e-04 | 79 | 33 | 3 | IPR019787 | |
| Domain | PHD | 5.15e-04 | 89 | 33 | 3 | SM00249 | |
| Domain | TPR_1 | 5.32e-04 | 90 | 33 | 3 | PF00515 | |
| Domain | TPR_1 | 5.32e-04 | 90 | 33 | 3 | IPR001440 | |
| Domain | Znf_PHD | 5.49e-04 | 91 | 33 | 3 | IPR001965 | |
| Domain | ZF_PHD_2 | 6.23e-04 | 95 | 33 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 6.42e-04 | 96 | 33 | 3 | PS01359 | |
| Domain | EPHD | 6.84e-04 | 22 | 33 | 2 | PS51805 | |
| Domain | TPR-like_helical_dom | 7.27e-04 | 233 | 33 | 4 | IPR011990 | |
| Domain | TPR | 1.51e-03 | 129 | 33 | 3 | SM00028 | |
| Domain | Znf_FYVE_PHD | 2.19e-03 | 147 | 33 | 3 | IPR011011 | |
| Domain | TPR-contain_dom | 2.32e-03 | 150 | 33 | 3 | IPR013026 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.98e-03 | 46 | 33 | 2 | IPR011042 | |
| Pathway | REACTOME_LGI_ADAM_INTERACTIONS | 1.77e-06 | 14 | 25 | 3 | MM15277 | |
| Pathway | REACTOME_LGI_ADAM_INTERACTIONS | 1.77e-06 | 14 | 25 | 3 | M27564 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 1.75e-05 | 29 | 25 | 3 | MM15028 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 2.14e-05 | 31 | 25 | 3 | M7223 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 2.60e-05 | 205 | 25 | 5 | M752 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | CACNG3 CACNG2 SCN11A CACNG8 KMT2D EFNB2 MAPK7 DPF3 INSM1 NRP1 | 8.85e-05 | 1432 | 25 | 10 | M509 |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 9.64e-05 | 270 | 25 | 5 | M15514 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.12e-04 | 144 | 25 | 4 | MM14501 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.97e-04 | 502 | 25 | 6 | MM14537 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 2.94e-04 | 74 | 25 | 3 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 2.94e-04 | 74 | 25 | 3 | M16376 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 3.56e-04 | 79 | 25 | 3 | M17673 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 4.02e-04 | 367 | 25 | 5 | M48346 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 4.12e-04 | 83 | 25 | 3 | M8728 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 4.82e-04 | 211 | 25 | 4 | MM14502 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 5.23e-04 | 90 | 25 | 3 | M835 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING | 6.21e-04 | 21 | 25 | 2 | M47950 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING | 6.21e-04 | 21 | 25 | 2 | M47949 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 6.74e-04 | 411 | 25 | 5 | M735 | |
| Pathway | WP_MAPK_SIGNALING | 8.58e-04 | 246 | 25 | 4 | M39597 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 8.83e-04 | 25 | 25 | 2 | M47948 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 1.16e-03 | 267 | 25 | 4 | M10792 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.45e-03 | 32 | 25 | 2 | M27455 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.13e-03 | 532 | 25 | 5 | M27870 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 2.67e-03 | 335 | 25 | 4 | MM14503 | |
| Pubmed | Functional modulation of AMPA receptors by transmembrane AMPA receptor regulatory proteins. | 3.11e-09 | 4 | 33 | 3 | 18304745 | |
| Pubmed | Critical role for TARPs in early development despite broad functional redundancy. | 3.11e-09 | 4 | 33 | 3 | 18634809 | |
| Pubmed | 2.72e-08 | 7 | 33 | 3 | 27076426 | ||
| Pubmed | Calcium channel gamma subunits: a functionally diverse protein family. | 4.34e-08 | 8 | 33 | 3 | 17652770 | |
| Pubmed | 6.51e-08 | 9 | 33 | 3 | 11170751 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 10221464 | ||
| Pubmed | PDZ binding of TARPγ-8 controls synaptic transmission but not synaptic plasticity. | 8.73e-07 | 2 | 33 | 2 | 22002768 | |
| Pubmed | TARP redundancy is critical for maintaining AMPA receptor function. | 8.73e-07 | 2 | 33 | 2 | 18753375 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 18000041 | ||
| Pubmed | TARPs differentially decorate AMPA receptors to specify neuropharmacology. | 8.73e-07 | 2 | 33 | 2 | 20219255 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 19549880 | ||
| Pubmed | A targeted mutation in Cacng4 exacerbates spike-wave seizures in stargazer (Cacng2) mice. | 2.62e-06 | 3 | 33 | 2 | 15677329 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 14505496 | ||
| Pubmed | Control of AMPA receptor activity by the extracellular loops of auxiliary proteins. | 2.62e-06 | 3 | 33 | 2 | 28871958 | |
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 12079276 | ||
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 20805473 | ||
| Pubmed | Separating genetic and hemodynamic defects in neuropilin 1 knockout embryos. | 1.31e-05 | 6 | 33 | 2 | 18550715 | |
| Pubmed | Molecular mechanisms controlling the migration of striatal interneurons. | 1.83e-05 | 7 | 33 | 2 | 26063906 | |
| Pubmed | Coronary vasculature patterning requires a novel endothelial ErbB2 holoreceptor. | 1.83e-05 | 7 | 33 | 2 | 27356767 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.91e-05 | 351 | 33 | 5 | 38297188 | |
| Pubmed | Hippocampal AMPA receptor gating controlled by both TARP and cornichon proteins. | 2.44e-05 | 8 | 33 | 2 | 21172611 | |
| Pubmed | BRG1 promotes COUP-TFII expression and venous specification during embryonic vascular development. | 3.13e-05 | 9 | 33 | 2 | 23406903 | |
| Pubmed | Tissue-specific venous expression of the EPH family receptor EphB1 in the skin vasculature. | 3.13e-05 | 9 | 33 | 2 | 23649798 | |
| Pubmed | 3.59e-05 | 197 | 33 | 4 | 36604605 | ||
| Pubmed | Single-cell multiomics decodes regulatory programs for mouse secondary palate development. | 3.91e-05 | 10 | 33 | 2 | 38280850 | |
| Pubmed | 4.78e-05 | 11 | 33 | 2 | 25315821 | ||
| Pubmed | Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. | 4.78e-05 | 11 | 33 | 2 | 15875024 | |
| Pubmed | VEGF/VEGFR2 signaling regulates hippocampal axon branching during development. | 4.78e-05 | 11 | 33 | 2 | 31868583 | |
| Pubmed | Accumulation of AMPA receptors in autophagosomes in neuronal axons lacking adaptor protein AP-4. | 4.78e-05 | 11 | 33 | 2 | 18341993 | |
| Pubmed | The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. | 4.78e-05 | 11 | 33 | 2 | 15510105 | |
| Pubmed | 5.73e-05 | 12 | 33 | 2 | 15457507 | ||
| Pubmed | 5.73e-05 | 12 | 33 | 2 | 36082581 | ||
| Pubmed | 6.77e-05 | 13 | 33 | 2 | 23395391 | ||
| Pubmed | 9.10e-05 | 15 | 33 | 2 | 33454003 | ||
| Pubmed | Neuropilin 1 and 2 control cranial gangliogenesis and axon guidance through neural crest cells. | 9.10e-05 | 15 | 33 | 2 | 18356247 | |
| Pubmed | The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. | 9.10e-05 | 15 | 33 | 2 | 15107403 | |
| Pubmed | Myocardium-derived angiopoietin-1 is essential for coronary vein formation in the developing heart. | 9.10e-05 | 15 | 33 | 2 | 25072663 | |
| Pubmed | Stepwise arteriovenous fate acquisition during mammalian vasculogenesis. | 9.10e-05 | 15 | 33 | 2 | 21793101 | |
| Pubmed | The protocadherin gene Celsr3 is required for interneuron migration in the mouse forebrain. | 9.10e-05 | 15 | 33 | 2 | 19332558 | |
| Pubmed | 9.10e-05 | 15 | 33 | 2 | 20568246 | ||
| Pubmed | An important role of endothelial hairy-related transcription factors in mouse vascular development. | 1.18e-04 | 17 | 33 | 2 | 25264302 | |
| Pubmed | 1.32e-04 | 18 | 33 | 2 | 16678147 | ||
| Pubmed | 1.32e-04 | 18 | 33 | 2 | 18093989 | ||
| Pubmed | Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. | 1.32e-04 | 18 | 33 | 2 | 18311135 | |
| Pubmed | 1.32e-04 | 18 | 33 | 2 | 19644017 | ||
| Pubmed | PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. | 1.48e-04 | 19 | 33 | 2 | 15239958 | |
| Pubmed | 1.48e-04 | 19 | 33 | 2 | 25958091 | ||
| Pubmed | 1.64e-04 | 20 | 33 | 2 | 25091710 | ||
| Pubmed | VEGF signaling through neuropilin 1 guides commissural axon crossing at the optic chiasm. | 1.64e-04 | 20 | 33 | 2 | 21658587 | |
| Pubmed | 1.81e-04 | 21 | 33 | 2 | 27789228 | ||
| Pubmed | Zic2-dependent axon midline avoidance controls the formation of major ipsilateral tracts in the CNS. | 2.18e-04 | 23 | 33 | 2 | 24360543 | |
| Pubmed | 2.18e-04 | 23 | 33 | 2 | 33830085 | ||
| Pubmed | Transient neuronal populations are required to guide callosal axons: a role for semaphorin 3C. | 2.18e-04 | 23 | 33 | 2 | 19859539 | |
| Pubmed | Hand2 is an essential regulator for two Notch-dependent functions within the embryonic endocardium. | 2.38e-04 | 24 | 33 | 2 | 25497097 | |
| Pubmed | UPF2 is a critical regulator of liver development, function and regeneration. | 2.38e-04 | 24 | 33 | 2 | 20657840 | |
| Pubmed | 2.38e-04 | 24 | 33 | 2 | 22632720 | ||
| Pubmed | 2.51e-04 | 129 | 33 | 3 | 23022380 | ||
| Pubmed | Mab21l2 is essential for embryonic heart and liver development. | 2.58e-04 | 25 | 33 | 2 | 22412967 | |
| Pubmed | 2.58e-04 | 25 | 33 | 2 | 24906954 | ||
| Pubmed | 2.80e-04 | 26 | 33 | 2 | 28193997 | ||
| Pubmed | Notch signaling is essential for ventricular chamber development. | 3.02e-04 | 27 | 33 | 2 | 17336907 | |
| Pubmed | 3.25e-04 | 28 | 33 | 2 | 35297995 | ||
| Pubmed | Extra-embryonic vasculature development is regulated by the transcription factor HAND1. | 3.25e-04 | 28 | 33 | 2 | 15073150 | |
| Pubmed | 3.74e-04 | 30 | 33 | 2 | 38636517 | ||
| Pubmed | 3.99e-04 | 31 | 33 | 2 | 27798109 | ||
| Pubmed | NOTCH maintains developmental cardiac gene network through WNT5A. | 4.25e-04 | 32 | 33 | 2 | 30347193 | |
| Pubmed | Semaphorin 3E/PlexinD1 signaling is required for cardiac ventricular compaction. | 4.25e-04 | 32 | 33 | 2 | 31434798 | |
| Pubmed | RC3H1 post-transcriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-κB pathway. | 4.38e-04 | 156 | 33 | 3 | 26170170 | |
| Pubmed | 4.46e-04 | 157 | 33 | 3 | 30186101 | ||
| Pubmed | 4.81e-04 | 34 | 33 | 2 | 26771085 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 5.32e-04 | 398 | 33 | 4 | 35016035 | |
| Pubmed | 5.68e-04 | 405 | 33 | 4 | 38187761 | ||
| Pubmed | 6.32e-04 | 1139 | 33 | 6 | 36417873 | ||
| Pubmed | Nephric duct insertion requires EphA4/EphA7 signaling from the pericloacal mesenchyme. | 7.00e-04 | 41 | 33 | 2 | 25139858 | |
| Pubmed | 8.06e-04 | 44 | 33 | 2 | 26471122 | ||
| Pubmed | 9.13e-04 | 201 | 33 | 3 | 23535732 | ||
| Pubmed | 9.19e-04 | 47 | 33 | 2 | 35462405 | ||
| Cytoband | 13q14.3 | 4.04e-04 | 41 | 33 | 2 | 13q14.3 | |
| Cytoband | 3p21.31 | 2.37e-03 | 100 | 33 | 2 | 3p21.31 | |
| GeneFamily | Calcium voltage-gated channel subunits | 6.71e-06 | 26 | 26 | 3 | 253 | |
| GeneFamily | PHD finger proteins | 2.85e-04 | 90 | 26 | 3 | 88 | |
| Drug | N-methyl-DL-aspartic acid | 2.57e-06 | 655 | 32 | 8 | CID000004376 | |
| Drug | Roxithromycin [80214-83-1]; Up 200; 4.8uM; HL60; HT_HG-U133A | 7.68e-06 | 197 | 32 | 5 | 2992_UP | |
| Drug | Naproxen [22204-53-1]; Up 200; 17.4uM; HL60; HT_HG-U133A | 8.26e-06 | 200 | 32 | 5 | 1869_UP | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; HL60; HT_HG-U133A | 8.26e-06 | 200 | 32 | 5 | 3056_UP | |
| Drug | manidipine | 9.35e-06 | 95 | 32 | 4 | CID000004008 | |
| Drug | nitrendipine | 1.06e-05 | 98 | 32 | 4 | CID000004507 | |
| Drug | lanthanum | 3.85e-05 | 136 | 32 | 4 | CID000023926 | |
| Drug | carbachol | 3.89e-05 | 688 | 32 | 7 | CID000002551 | |
| Drug | ST 900 | 4.00e-05 | 7 | 32 | 2 | CID000107800 | |
| Drug | nimodipine | 4.94e-05 | 145 | 32 | 4 | CID000004497 | |
| Drug | antipyrine | 5.63e-05 | 53 | 32 | 3 | CID000002206 | |
| Drug | procaine | 6.09e-05 | 153 | 32 | 4 | CID000004914 | |
| Drug | Cinildipine | 6.65e-05 | 56 | 32 | 3 | CID000002752 | |
| Drug | 2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide | 6.85e-05 | 9 | 32 | 2 | ctd:C000516 | |
| Drug | halothane | 7.17e-05 | 314 | 32 | 5 | CID000003562 | |
| Drug | amiloride | 7.28e-05 | 315 | 32 | 5 | CID000016230 | |
| Drug | nilvadipine | 8.17e-05 | 60 | 32 | 3 | CID000004494 | |
| Drug | gabapentin | 8.96e-05 | 169 | 32 | 4 | CID000003446 | |
| Drug | lercanidipine | 9.46e-05 | 63 | 32 | 3 | CID000065866 | |
| Drug | chlorpyrifos oxon | 9.91e-05 | 64 | 32 | 3 | CID000021804 | |
| Drug | mibefradil | 9.91e-05 | 64 | 32 | 3 | CID000060662 | |
| Drug | F(420 | 1.14e-04 | 67 | 32 | 3 | CID000122079 | |
| Drug | gallopamil | 1.14e-04 | 67 | 32 | 3 | CID000001234 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.14e-04 | 180 | 32 | 4 | 1793_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.17e-04 | 181 | 32 | 4 | 6951_DN | |
| Drug | genistein | 1.20e-04 | 1117 | 32 | 8 | CID005280961 | |
| Drug | AC1L2AC7 | 1.24e-04 | 69 | 32 | 3 | CID000068733 | |
| Drug | NSC759576 | 1.44e-04 | 191 | 32 | 4 | CID000003075 | |
| Drug | CAS 298-57-7 | 1.47e-04 | 73 | 32 | 3 | CID000002761 | |
| Drug | Testosterone propionate [57-85-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.49e-04 | 193 | 32 | 4 | 4676_UP | |
| Drug | Harmine hydrochloride [343-27-1]; Up 200; 16uM; PC3; HT_HG-U133A | 1.52e-04 | 194 | 32 | 4 | 5855_UP | |
| Drug | alpha-Santonin [481-06-1]; Down 200; 16.2uM; PC3; HT_HG-U133A | 1.52e-04 | 194 | 32 | 4 | 3795_DN | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; PC3; HT_HG-U133A | 1.52e-04 | 194 | 32 | 4 | 6727_UP | |
| Drug | Yohimbinic acid monohydrate [27801-27-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.52e-04 | 194 | 32 | 4 | 4082_UP | |
| Drug | ethosuximide | 1.53e-04 | 74 | 32 | 3 | CID000003291 | |
| Drug | Budesonide [51333-22-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.55e-04 | 195 | 32 | 4 | 6330_UP | |
| Drug | Thioperamide maleate [106243-16-7]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.55e-04 | 195 | 32 | 4 | 3392_DN | |
| Drug | Cyproterone acetate [427-51-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 3545_UP | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 4773_UP | |
| Drug | Tetrahydroalstonine [6474-90-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 5728_DN | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 1uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 4758_UP | |
| Drug | Felbinac [5728-52-9]; Up 200; 18.8uM; PC3; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 4639_UP | |
| Drug | Lorglumide sodium salt [97964-56-2]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 4658_UP | |
| Drug | Articaine hydrochloride [23964-57-0]; Up 200; 12.4uM; HL60; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 3138_UP | |
| Drug | Pancuronium bromide [15500-66-0]; Up 200; 5.4uM; PC3; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 4570_UP | |
| Drug | Vitamin K2 [11032-49-8]; Down 200; 9uM; PC3; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 3798_DN | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 3355_UP | |
| Drug | Androsterone [53-41-8]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 2650_UP | |
| Drug | Ceforanide [60925-61-3]; Up 200; 7.6uM; PC3; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 6751_UP | |
| Drug | Ethoxyquin [91-53-2]; Up 200; 18.4uM; HL60; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 2559_UP | |
| Drug | Chlorambucil [305-03-3]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 4345_UP | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 1uM; PC3; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 3736_UP | |
| Drug | Convolamine hydrochloride [500-56-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 5876_UP | |
| Drug | 5186324; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 1.68e-04 | 199 | 32 | 4 | 900_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 3935_UP | |
| Drug | Naringin hydrate [11032-30-7]; Up 200; 6.6uM; PC3; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 4605_UP | |
| Drug | Sulfabenzamide [127-71-9]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 2814_UP | |
| Drug | milbemycin | 1.72e-04 | 14 | 32 | 2 | ctd:C027837 | |
| Drug | nisoldipine | 1.79e-04 | 78 | 32 | 3 | CID000004499 | |
| Drug | dihydrosafrole | 1.99e-04 | 15 | 32 | 2 | CID000007197 | |
| Drug | doramectin | 1.99e-04 | 15 | 32 | 2 | ctd:C084101 | |
| Drug | phenytoin | 2.42e-04 | 219 | 32 | 4 | CID000001775 | |
| Drug | AC1NUZ8M | 2.91e-04 | 92 | 32 | 3 | CID000073211 | |
| Drug | pervanadate | 3.22e-04 | 19 | 32 | 2 | ctd:C076715 | |
| Drug | isradipine | 3.72e-04 | 100 | 32 | 3 | CID000003784 | |
| Drug | chlorpyrifos | 3.83e-04 | 101 | 32 | 3 | CID000002730 | |
| Drug | cyclothiazide | 4.05e-04 | 103 | 32 | 3 | CID000002910 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.59e-05 | 45 | 32 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 7.13e-05 | 74 | 32 | 3 | DOID:3748 (is_marker_for) | |
| Disease | triiodothyronine measurement | 1.35e-04 | 16 | 32 | 2 | EFO_0008392 | |
| Disease | Nephrotic Syndrome | 3.93e-04 | 27 | 32 | 2 | C0027726 | |
| Disease | prostate cancer (is_marker_for) | 6.42e-04 | 156 | 32 | 3 | DOID:10283 (is_marker_for) | |
| Disease | Arthritis, Adjuvant-Induced | 8.66e-04 | 40 | 32 | 2 | C0003865 | |
| Disease | Arthritis, Collagen-Induced | 8.66e-04 | 40 | 32 | 2 | C0971858 | |
| Disease | Arthritis, Experimental | 8.66e-04 | 40 | 32 | 2 | C0993582 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 2.14e-03 | 63 | 32 | 2 | DOID:0050866 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.20e-03 | 64 | 32 | 2 | DOID:4947 (is_marker_for) | |
| Disease | Schizophrenia | 2.44e-03 | 883 | 32 | 5 | C0036341 | |
| Disease | migraine disorder, endometriosis | 2.85e-03 | 73 | 32 | 2 | EFO_0001065, MONDO_0005277 | |
| Disease | longitudinal BMI measurement | 3.58e-03 | 82 | 32 | 2 | EFO_0005937 | |
| Disease | Mechanical Allodynia | 3.76e-03 | 84 | 32 | 2 | C2936719 | |
| Disease | Hyperalgesia | 3.76e-03 | 84 | 32 | 2 | C0020429 | |
| Disease | Allodynia | 3.76e-03 | 84 | 32 | 2 | C0458247 | |
| Disease | Hyperalgesia, Secondary | 3.76e-03 | 84 | 32 | 2 | C0751212 | |
| Disease | Hyperalgesia, Primary | 3.76e-03 | 84 | 32 | 2 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 3.76e-03 | 84 | 32 | 2 | C0751214 | |
| Disease | Tactile Allodynia | 3.76e-03 | 84 | 32 | 2 | C0751213 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NSFIFKYADPDRECH | 601 | Q15303 | |
| AAADPHECYAKVFDE | 386 | P02768 | |
| VCKKIDHFPEDADYE | 76 | O60359 | |
| CYEAESPDEAALVHA | 716 | O94823 | |
| AAHDLAFACKLDYDE | 201 | Q8NFI4 | |
| LCKQIDHFPEDADYE | 76 | Q9Y698 | |
| FLAKYHDPDDEPDCA | 346 | Q13164 | |
| CAFPTHYEEALKDEE | 301 | O15479 | |
| HDAASQEDHDKPYVC | 186 | Q92784 | |
| PDCYFLNSKDAFVHD | 141 | Q9UN88 | |
| ADSVFCPHYEKVSGD | 296 | P52799 | |
| DVFNHYPFAECHETD | 846 | Q8IXT1 | |
| LPEADYHEFLECAHE | 1486 | Q6ZR08 | |
| QVFVKCHFDYDPARD | 251 | Q14168 | |
| EEPLDKSYDFISHCA | 1391 | O15230 | |
| AAAEEDIADPFFAYC | 481 | O94880 | |
| DIADPFFAYCKQHAD | 486 | O94880 | |
| FNPHFDLEDRDCKYD | 71 | O14786 | |
| CVKINHFPEDTDYDH | 101 | Q8WXS5 | |
| GYESACKDFVPHDLE | 21 | A0PJE2 | |
| NAAAFLKCVEHAYEP | 281 | Q9ULC5 | |
| LCKEEYADPFALAQH | 271 | Q01101 | |
| EAAHDLALACKFDYD | 196 | Q8IZP2 | |
| DLCEEALRHYEDFPK | 696 | O94906 | |
| HACFPDTAVDYFGKA | 466 | O95785 | |
| VEYEAHSDDKCEPKY | 311 | Q969I6 | |
| SALEKHGPVYEDDCF | 136 | P13798 | |
| VHFEADTYKDPFCSK | 426 | Q96JQ2 | |
| EVECNYHCYHEKDPD | 21 | Q96BR5 | |
| EDKHFQSYCLLEAAP | 386 | Q9NNW5 | |
| LEPEAAAQAHYKACD | 46 | O14904 | |
| ALHTADKPYECEECD | 291 | P17035 | |
| AYDHCFEKKENSPEF | 296 | Q9UI33 | |
| DYQFDFEDDQHKIPC | 5511 | O14686 |